Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr;18(2):291-319, vii-viii.
doi: 10.1016/j.chc.2008.12.005.

Comorbidity in pediatric bipolar disorder

Affiliations
Review

Comorbidity in pediatric bipolar disorder

Gagan Joshi et al. Child Adolesc Psychiatr Clin N Am. 2009 Apr.

Abstract

The growing literature shows the pervasiveness and importance of comorbidity in youth with bipolar disorder (BPD). For instance, up to 90% of youth with BPD have been described to manifest comorbidity with attention-deficit hyperactivity disorder. Multiple anxiety, substance use, and disruptive behavior disorders are the other most commonly reported comorbidities with BPD. Moreover, important recent data highlight the importance of obsessive-compulsive and pervasive developmental illness in the context of BPD. Data suggest that not only special developmental relationships are operant in the context of comorbidity but also that the presence of comorbid disorders with BPD results in a more severe clinical condition. Moreover, the presence of comorbidity has therapeutic implications for the treatment response for both BPD and the associated comorbid disorder. Future longitudinal studies to address the relationship and the impact of comorbid disorders on course and therapeutic response over time are required in youth with BPD.

PubMed Disclaimer

Figures

Figure-1
Figure-1
Rates of Psychiatric Comorbidity in Bipolar Youth Stratified by Age at Onset of BPD
Figure-2
Figure-2
Risk of SUD in Psychiatrically Referred Adolescent Outpatient Population
Figure-3
Figure-3
Development of Substance Use Disorders in Child & Adolescent-Onset BPD Adolescent Onset Bipolar (>12 years) N=38
Figure-4
Figure-4
Anxiety Disorders in Clinically Referred Youth with Bipolar Disorder
Figure-5
Figure-5
Endpoint YMRS Score Mean Change BPD+OCD Vs. BPD+GAD

Similar articles

Cited by

References

    1. Diagnostic and Statistical Manual of Mental Disorders. 4th. Washington, D.C: American Psychiatric Association;
    1. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266. - PubMed
    1. Research Units on Pediatric Psychopharmacology Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314. - PubMed
    1. Aman MG, Arnold MDL, McDougle CJ, et al. Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol. 2005;15:869. - PubMed
    1. Aman MG, De Smedt G, Derivan A, et al. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry. 2002;159:1337. - PubMed

Publication types

MeSH terms